Skip to Content
Global News Select

Anthem 4Q Profit Falls, Revenue Rises

By Dave Sebastian


Anthem Inc. said its profit for the fourth quarter fell despite higher revenue as the return of the health-insurance tax drove expenses up and non-Covid-19 health-care activity remained lower during the pandemic.

The health insurer on Wednesday posted net income of $551 million, or $2.19 a share, compared with $934 million, or $3.62 a share, in the year-ago period.

Adjusted earnings were $2.54 a share. Analysts polled by FactSet were expecting $2.53 a share.

The medical-loss ratio, the share of premiums the insurer pays out in claims, was 88.9% for the quarter, compared with 89% in the prior-year quarter due to lower non-Covid health-care activity during the pandemic. Analysts were expecting 89.9%.

Revenue rose 16% to $31.82 billion from $27.41 billion, driven by growth in Medicaid and Medicare, as well as pharmacy-product revenue related to IngenioRx. Analysts were looking for $30.9 billion.

Expenses grew 19% to $31.21 billion, partly driven by the return of the health-insurance tax.

The company had about 42.9 million members as of Dec. 31, up 4.7% from the year-ago period.


Write to Dave Sebastian at


(END) Dow Jones Newswires

January 27, 2021 06:34 ET (11:34 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.